Marshall Wace North America
CNXC icon

Marshall Wace North America’s Concentrix CNXC Stock Holding History

Marshall Wace North America’s Portfolio CNXC Stock Details CNXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$17.6M Sell
99,268
-10,932
-10% -$1.81M 0.07% 253
2021
Q2 		$17.7M Buy
110,200
+102,350
+1,304% +$15.7M 0.07% 277
2021
Q1 		$1.18M Buy
+7,850
New +$951K ﹤0.01% 990

Other funds holding CNXC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Lyrical Asset Management
Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

Marshall Wace North America's CNXC Position: Q3 2021 in Review

Marshall Wace North America reduced its Concentrix (CNXC) stake by 9.9% in Q3 2021, selling an estimated $1.81M and leaving 99,268 shares worth $17.6M. The position accounts for 0.07% of the portfolio, ranked #253.

Marshall Wace North America first reported a position in CNXC in Q1 2021 and has held it in 3 quarters since. The position peaked at $17.7M in Q2 2021. 317 funds tracked by Wall St. Rank hold CNXC as of Q3 2021.

  • Marshall Wace North America held 99,268 shares of Concentrix worth $17.6M as of Q3 2021.
  • Marshall Wace North America sold 10,932 Concentrix shares in Q3 2021, an estimated $1.81M.
  • Concentrix made up 0.07% of Marshall Wace North America's portfolio in Q3 2021, its #253 holding.
  • Marshall Wace North America first reported a position in Concentrix in Q1 2021 and has held it in 3 quarters since.
  • Marshall Wace North America's Concentrix position peaked at $17.7M in Q2 2021.
  • 317 funds tracked by Wall St. Rank held Concentrix as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.